Literature DB >> 23876995

Calcification of the mitral valve and annulus: systematic evaluation of effects on valve anatomy and function.

Rajesh Movva1, Kinnari Murthy1, Abel Romero-Corral1, Harish Raj Seetha Rammohan1, Peter Fumo1, Gregg S Pressman2.   

Abstract

BACKGROUND: Mitral annular calcification (MAC) is common in chronic kidney disease. It is associated with cardiovascular events and can cause valvular dysfunction, but it has not been systematically characterized. The aim of this prospective study was to assess the prevalence and distribution of MAC, its effects on leaflet motion, and its association with mitral stenosis and mitral regurgitation (MR) in a hemodialysis population.
METHODS: Echocardiograms were obtained in 75 consecutive hemodialysis outpatients. MAC extent and distribution were graded semiquantitatively using two-dimensional and three-dimensional echocardiography. Associations with the presence and severity of mitral stenosis and MR were explored.
RESULTS: The mean age was 60 ± 14 years; 60% were men, and 87% were African American. MAC was present in 64% (moderate to severe in 48%). Calcium extended more than halfway onto the leaflet in 37% and beyond the annulus in 40%. Leaflet motion was restricted in 37%. Mitral stenosis was present in 28%, and the extent of calcification was associated with mean mitral valve gradient (P < .0001). MR was prevalent (present in 81%) but was severe in none. The severity of MAC was greater in patients with moderate MR than in those with no or mild MR (P = .04). Three-dimensional analysis suggested an uneven distribution of annular calcium; the middle and lateral anterior segments were less often calcified than the anterior-medial or posterior segments. Calcification in any annular segment was highly associated with restricted motion of the attached leaflet segment.
CONCLUSIONS: MAC is common and often extensive in hemodialysis patients. Calcium may be unevenly distributed among the annular segments. When present, annular calcification reduces the angle of leaflet opening and can cause valvular dysfunction.
Copyright © 2013 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  Hemodialysis; MAC; MR; MS; Mitral annular calcification; Mitral regurgitation; Mitral stenosis

Mesh:

Year:  2013        PMID: 23876995     DOI: 10.1016/j.echo.2013.06.014

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  12 in total

Review 1.  Mitral annular calcification: challenges and future perspectives.

Authors:  Mathias Van Hemelrijck; Maurizio Taramasso; Gökhan Gülmez; Francesco Maisano; Carlos-A Mestres
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-01-27

2.  Prognostic importance of the transmitral pressure gradient in mitral annular calcification with associated mitral valve dysfunction.

Authors:  Philippe B Bertrand; Timothy W Churchill; Evin Yucel; Mayooran Namasivayam; Samuel Bernard; Yasufumi Nagata; Wei He; Carl T Andrews; Michael H Picard; Arthur E Weyman; Robert A Levine; Judy Hung
Journal:  Eur Heart J       Date:  2020-12-01       Impact factor: 29.983

Review 3.  Mitral Annular Calcification: Association with Atherosclerosis and Clinical Implications.

Authors:  Luiz Rafael P Cavalcanti; Michel Pompeu B O Sá; Álvaro M Perazzo; Antonio C Escorel Neto; Rafael A F Gomes; Alexander Weymann; Konstantin Zhigalov; Arjang Ruhparwar; Ricardo C Lima
Journal:  Curr Atheroscler Rep       Date:  2020-02-07       Impact factor: 5.113

4.  Altered Responsiveness to TGFβ and BMP and Increased CD45+ Cell Presence in Mitral Valves Are Unique Features of Ischemic Mitral Regurgitation.

Authors:  Estibaliz Castillero; Daniel P Howsmon; Bruno V Rego; Samuel J Keeney; Kathryn H Driesbaugh; Takayuki Kawashima; Yingfei Xue (薛应騛); Chiara Camillo; Isaac George; Robert C Gorman; Joseph H Gorman; Michael S Sacks; Robert J Levy; Giovanni Ferrari
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-04-08       Impact factor: 10.514

5.  Mitral Valve Annuloplasty Ring Dehiscence Diagnosed Intraoperative With Real-Time 3D Transesophageal Echocardiogram.

Authors:  Karina Castellon-Larios; Alix Zuleta-Alarcon; Antolin Flores; Michelle Humeidan; Andrew N Springer; Michael Essandoh
Journal:  J Investig Med High Impact Case Rep       Date:  2014-06-24

6.  Quantitative analysis of mitral valve morphology in atrial functional mitral regurgitation using real-time 3-dimensional echocardiography atrial functional mitral regurgitation.

Authors:  Tao Cong; Jinping Gu; Alex Pui-Wai Lee; Zhijuan Shang; Yinghui Sun; Qiaobing Sun; Hong Wei; Na Chen; Siyao Sun; Tingting Fu
Journal:  Cardiovasc Ultrasound       Date:  2018-08-21       Impact factor: 2.062

7.  Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement.

Authors:  Victor Mauri; Maria I Körber; Elmar Kuhn; Tobias Schmidt; Christian Frerker; Thorsten Wahlers; Tanja K Rudolph; Stephan Baldus; Matti Adam; Henrik Ten Freyhaus
Journal:  Clin Res Cardiol       Date:  2020-02-18       Impact factor: 5.460

8.  Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification.

Authors:  Antonio Bellasi; Paolo Raggi; Jordi Bover; David A Bushinsky; Glenn M Chertow; Markus Ketteler; Mariano Rodriguez; Smeeta Sinha; Carolina Salcedo; Rekha Garg; Alex Gold; Joan Perelló
Journal:  Clin Kidney J       Date:  2019-10-30

9.  Chameleonic appearance of caseous calcification of the mitral valve - still a problem for its appropriate management.

Authors:  Caius Glad Streian; Ana Lascu; Raluca Şoşdean; Ciprian Nicuşor Dima; Florin Grosu; Adrian Costache; Andrei Gheorghe Marius Motoc
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

10.  Impact of the distribution of epicardial and visceral adipose tissue on left ventricular diastolic function.

Authors:  Kosuke Takahari; Hiroto Utsunomiya; Kiho Itakura; Hideya Yamamoto; Yukiko Nakano
Journal:  Heart Vessels       Date:  2021-07-06       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.